Citrus limonin glucoside supplementation decreased biomarkers of liver disease and inflammation in overweight human adults

Citrus limonin glucoside supplementation decreased biomarkers of liver disease and inflammation in overweight human adults

Mixtures of limonoid glucosides demonstrated health benefits in human and animal studies; however, the specific metabolic effects of purified citrus limonin glucoside (LG) in humans are unknown. We determined effects of LG on circulating biomarkers of chronic inflammatory diseases such as nonalcohol...

Full description

Bibliographic Details
Main Authors:	Darshan S. Kelley, Yuriko C. Adkins, Susan J. Zunino, Leslie R. Woodhouse, Ellen L. Bonnel, Andrew P. Breksa, III, Gary D. Manners, Bruce E. Mackey
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Series:	Journal of Functional Foods
Subjects:	Liver enzymes Metabolic syndrome Nonalcoholic fatty liver disease Cardiovascular disease Obesity Inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S1756464614003764

Similar Items

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
by: Hassan Pakravan, et al.
Published: (2017-01-01)

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019
by: Juan Pang, et al.
Published: (2022-08-01)

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Modifications decrease hepatic steatosis in Taiwanese with metabolic‐associated fatty liver disease
by: Tso‐Tsai Liu, et al.
Published: (2022-10-01)

The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review
by: Grant J. Herrington, et al.
Published: (2022-08-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

The effect of symbiotic supplementation on liver enzymes, c-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: A clinical trial
by: Atefe Asgharian, et al.
Published: (2016-01-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)

Citrus maxima and tea regulate AMPK signaling pathway to retard the progress of nonalcoholic fatty liver disease
by: Shuai Wen, et al.
Published: (2022-06-01)

Nonalcoholic Fatty Liver Disease and Risk of Early-Onset Vasomotor Symptoms in Lean and Overweight Premenopausal Women
by: Yoosun Cho, et al.
Published: (2022-07-01)

Pathogenetic and clinical significance of the gut-liver microbiota axis
by: D. T. Dicheva, et al.
Published: (2022-05-01)

Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases
by: Xianhui Zeng, et al.
Published: (2021-07-01)

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks
by: Chengfei Jiang, et al.
Published: (2020-11-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Non-invasive evaluation of liver stiffness in nonalcoholic fatty liver disease: supersonic shear imaging, FibroScan or ARFI?
by: Coskun Ozturker, et al.
Published: (2016-12-01)

Nonalcoholic fatty liver disease and non-liver comorbidities
by: Richie Manikat, et al.
Published: (2023-02-01)

Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study
by: Kil Woo Lee, et al.
Published: (2015-12-01)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Byoung Kuk Jang
Published: (2012-12-01)

Spinach consumption and nonalcoholic fatty liver disease among adults: a case–control study
by: Ebrahim Mokhtari, et al.
Published: (2021-05-01)

The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study
by: Guiyan Yang, et al.
Published: (2023-02-01)

Metabolically associated fatty liver disease – a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022-07-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
by: Weijun Gu, et al.
Published: (2022-03-01)

Multifocal fatty liver nodules mimicking a metastatic disease: A case report
by: Huy Quang Duong, et al.
Published: (2024-03-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

The role of the microbiome in NAFLD and NASH
by: Aleksandra A Kolodziejczyk, et al.
Published: (2019-02-01)

Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
by: David Højland Ipsen, et al.
Published: (2021-01-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

Analysis of the association between dietary patterns and nonalcoholic fatty liver disease in a county in Guangxi
by: Song Xiao, et al.
Published: (2023-09-01)